Free Trial
→ Elon’s BIGGEST warning yet? (From Brownstone Research) (Ad) Free UHT Stock Alerts

Universal Health Realty Income Trust (UHT) Financials

Universal Health Realty Income Trust logo
$38.68 +0.65 (+1.71%)
Closing price 03:59 PM Eastern
Extended Trading
$38.76 +0.08 (+0.21%)
As of 04:24 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare
Annual Income Statements for Universal Health Realty Income Trust

Annual Income Statements for Universal Health Realty Income Trust

This table shows Universal Health Realty Income Trust's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2022 2023 2024
Period end date 12/31/2022 12/31/2023 12/31/2024
Net Income / (Loss) Attributable to Common Shareholders		 21 15 19
Consolidated Net Income / (Loss)		 21 15 19
Net Income / (Loss) Continuing Operations		 32 32 38
Total Pre-Tax Income 		31 31 37
Total Revenue		 91 95 99
Net Interest Income / (Expense)		 0.00 0.00 0.00
Total Interest Income		 0.00 0.00 0.00
Total Interest Expense		 0.00 0.00 0.00
Total Non-Interest Income		 91 95 99
Other Service Charges		 3.19 2.50 2.29
Net Realized & Unrealized Capital Gains on Investments		 0.00 -0.23 0.00
Other Non-Interest Income		 87 93 97
Total Non-Interest Expense		 60 64 62
Other Operating Expenses		 33 36 35
Depreciation Expense		 27 28 27
Other Gains / (Losses), net		 1.19 1.21 1.28
Other Adjustments to Consolidated Net Income / (Loss)		 -11 -17 -19
Basic Earnings per Share		 $1.53 $1.12 $1.39
Weighted Average Basic Shares Outstanding		 13.77M 13.79M 13.80M
Diluted Earnings per Share		 $1.53 $1.11 $1.39
Weighted Average Diluted Shares Outstanding		 13.80M 13.81M 13.84M
Weighted Average Basic & Diluted Shares Outstanding		 13.80M 13.82M 13.85M
Cash Dividends to Common per Share		 $2.84 $2.88 $2.92

Quarterly Income Statements for Universal Health Realty Income Trust

This table shows Universal Health Realty Income Trust's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Period end date 9/30/2022 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024
Net Income / (Loss) Attributable to Common Shareholders		 4.85 5.63 4.46 3.48 3.87 3.59 5.30 5.28 4.00 4.66
Consolidated Net Income / (Loss)		 4.85 5.63 4.46 3.48 3.87 3.59 5.30 5.28 4.00 4.66
Net Income / (Loss) Continuing Operations		 7.67 14 8.16 7.65 8.34 8.18 9.85 9.86 8.79 9.58
Total Pre-Tax Income 		7.32 8.73 7.79 7.38 8.03 7.92 9.46 9.58 8.49 9.26
Total Revenue		 22 24 23 24 24 24 25 25 24 25
Total Non-Interest Income		 22 24 23 24 24 24 25 25 24 25
Other Service Charges		 0.48 1.76 0.71 0.54 0.66 0.59 0.63 0.56 0.55 0.55
Other Non-Interest Income		 22 22 23 23 24 24 25 24 24 24
Total Non-Interest Expense		 15 11 15 16 16 16 16 15 16 15
Other Operating Expenses		 8.17 4.30 8.82 9.57 9.19 8.91 8.87 8.34 9.00 8.59
Depreciation Expense		 6.66 6.51 6.62 6.85 7.01 7.25 6.81 6.81 7.01 6.80
Other Gains / (Losses), net		 0.35 0.25 0.37 0.27 0.31 0.25 0.38 0.27 0.30 0.32
Other Adjustments to Consolidated Net Income / (Loss)		 -2.82 - -3.70 -4.18 -4.47 -4.58 -4.55 -4.58 -4.79 -4.92
Basic Earnings per Share		 $0.35 $0.41 $0.32 $0.25 $0.28 $0.27 $0.38 $0.38 $0.29 $0.34
Weighted Average Basic Shares Outstanding		 13.78M 13.77M 13.78M 13.78M 13.79M 13.79M 13.79M 13.80M 13.81M 13.80M
Diluted Earnings per Share		 $0.35 $0.41 $0.32 $0.25 $0.28 $0.26 $0.38 $0.38 $0.29 $0.34
Weighted Average Diluted Shares Outstanding		 13.80M 13.80M 13.80M 13.81M 13.82M 13.81M 13.82M 13.83M 13.85M 13.84M
Weighted Average Basic & Diluted Shares Outstanding		 13.80M 13.80M 13.80M 13.82M 13.82M 13.82M 13.83M 13.85M 13.85M 13.85M

Annual Cash Flow Statements for Universal Health Realty Income Trust

This table details how cash moves in and out of Universal Health Realty Income Trust's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2022 2023 2024
Period end date 12/31/2022 12/31/2023 12/31/2024
Net Change in Cash & Equivalents		 -15 0.60 -1.12
Net Cash From Operating Activities		 47 43 47
Net Cash From Continuing Operating Activities		 47 43 47
Net Income / (Loss) Continuing Operations		 21 15 19
Consolidated Net Income / (Loss)		 21 15 19
Depreciation Expense		 27 28 27
Amortization Expense		 0.52 0.55 0.59
Non-Cash Adjustments to Reconcile Net Income		 0.78 -0.76 0.85
Changes in Operating Assets and Liabilities, net		 -2.16 0.02 -1.19
Net Cash From Investing Activities		 -37 -19 -14
Net Cash From Continuing Investing Activities		 -37 -19 -14
Purchase of Property, Leasehold Improvements and Equipment		 -14 -7.62 0.00
Acquisitions		 -1.35 0.00 0.00
Purchase of Investment Securities		 -0.09 -4.06 -5.89
Sale and/or Maturity of Investments		 0.00 7.39 0.00
Other Investing Activities, net		 -22 -15 -7.98
Net Cash From Financing Activities		 -25 -23 -34
Net Cash From Continuing Financing Activities		 -25 -23 -34
Issuance of Debt		 26 29 22
Issuance of Common Equity		 0.18 0.15 -0.13
Repayment of Debt		 -12 -12 -14
Repurchase of Common Equity		 0.00 0.00 0.00
Payment of Dividends		 -39 -40 -40
Other Financing Activities, Net		 -0.03 -0.22 -2.38
Cash Interest Paid		 10 16 18

Quarterly Cash Flow Statements for Universal Health Realty Income Trust

This table details how cash moves in and out of Universal Health Realty Income Trust's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Period end date 9/30/2022 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024
Net Change in Cash & Equivalents		 -0.30 -0.49 0.51 1.34 -1.10 -0.15 -0.52 -2.12 0.80 0.73
Net Cash From Operating Activities		 9.58 12 10 12 10 10 12 12 9.89 13
Net Cash From Continuing Operating Activities		 9.58 12 10 12 10 10 12 12 9.89 13
Net Income / (Loss) Continuing Operations		 4.85 5.63 4.46 3.48 3.87 3.59 5.30 5.28 4.00 4.66
Consolidated Net Income / (Loss)		 4.85 5.63 4.46 3.48 3.87 3.59 5.30 5.28 4.00 4.66
Depreciation Expense		 6.66 6.51 6.62 6.85 7.01 7.25 6.81 6.81 7.01 6.80
Amortization Expense		 0.13 0.13 0.12 0.13 0.14 0.16 0.15 0.15 0.15 0.15
Non-Cash Adjustments to Reconcile Net Income		 -0.49 1.61 -0.01 -0.22 0.81 -1.33 -0.18 0.59 -0.88 1.32
Changes in Operating Assets and Liabilities, net		 -1.57 -1.59 -1.12 2.02 -1.67 0.79 -0.34 -0.69 -0.38 0.23
Net Cash From Investing Activities		 -5.44 -5.43 -5.41 -3.48 -11 0.74 -8.95 -0.72 -1.50 -2.71
Net Cash From Continuing Investing Activities		 -5.44 -5.43 -5.41 -3.48 -11 0.74 -8.95 -0.72 -1.50 -2.71
Other Investing Activities, net		 -5.35 -5.43 -5.04 -3.48 -3.17 -3.14 -3.05 -0.72 -1.50 -2.71
Net Cash From Financing Activities		 -4.43 -7.35 -4.15 -7.43 -0.31 -11 -3.31 -14 -7.60 -9.72
Net Cash From Continuing Financing Activities		 -4.43 -7.35 -4.15 -7.43 -0.31 -11 -3.31 -14 -7.60 -9.72
Issuance of Debt		 5.80 8.00 10 3.00 10 5.10 7.05 9.25 4.85 1.15
Issuance of Common Equity		 0.04 0.04 0.04 0.04 0.04 0.03 0.04 -0.05 0.03 -0.15
Repayment of Debt		 -0.49 -5.54 -4.61 -0.38 -0.43 -6.47 -0.37 -13 -0.31 -0.32
Payment of Dividends		 -9.78 -9.85 -9.85 -9.99 -9.93 -10.00 -10 -10 -10 -10
Other Financing Activities, Net		 - - -0.03 -0.10 -0.09 - -0.03 -0.02 -2.08 -0.25
Cash Interest Paid		 2.72 3.34 3.72 4.01 4.30 4.23 3.76 4.46 4.92 4.77

Annual Balance Sheets for Universal Health Realty Income Trust

This table presents Universal Health Realty Income Trust's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2022 2023 2024
Period end date 12/31/2022 12/31/2023 12/31/2024
Total Assets		 608 596 581
Cash and Due from Banks		 7.61 8.21 7.10
Loans and Leases, Net of Allowance		 0.00 0.00 0.00
Premises and Equipment, Net		 461 455 437
Intangible Assets		 9.45 9.11 7.33
Other Assets		 107 124 130
Total Liabilities & Shareholders' Equity		 608 596 581
Total Liabilities		 378 395 401
Non-Interest Bearing Deposits		 11 11 11
Short-Term Debt		 298 327 349
Accrued Interest Payable		 0.37 0.49 0.69
Long-Term Debt		 45 33 19
Other Long-Term Liabilities		 24 24 21
Total Equity & Noncontrolling Interests		 229 201 180
Total Preferred & Common Equity		 229 201 180
Preferred Stock		 0.00 0.00 0.00
Total Common Equity		 229 201 180
Common Stock		 270 271 271
Retained Earnings		 -53 -77 -98
Accumulated Other Comprehensive Income / (Loss)		 12 7.31 6.41

Quarterly Balance Sheets for Universal Health Realty Income Trust

This table presents Universal Health Realty Income Trust's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024
Period end date 9/30/2022 3/31/2023 6/30/2023 9/30/2023 3/31/2024 6/30/2024 9/30/2024
Total Assets		 609 604 603 608 596 587 584
Cash and Due from Banks		 8.10 8.12 9.46 8.36 7.70 5.58 6.37
Loans and Leases, Net of Allowance		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Premises and Equipment, Net		 461 459 458 461 450 445 441
Intangible Assets		 9.94 8.88 8.34 9.65 8.65 8.19 7.76
Other Assets		 107 107 107 107 130 128 129
Total Liabilities & Shareholders' Equity		 609 604 603 608 596 587 584
Total Liabilities		 376 382 386 398 400 396 403
Non-Interest Bearing Deposits		 9.91 11 11 12 11 11 11
Short-Term Debt		 290 308 311 322 334 343 348
Accrued Interest Payable		 0.35 0.34 0.34 0.33 1.09 1.02 0.74
Long-Term Debt		 50 40 40 39 33 20 20
Other Long-Term Liabilities		 25 22 24 25 21 21 24
Total Equity & Noncontrolling Interests		 234 222 217 210 196 191 182
Total Preferred & Common Equity		 234 222 217 210 196 191 182
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 234 222 217 210 196 191 182
Common Stock		 269 270 270 270 271 271 271
Retained Earnings		 -48 -58 -64 -70 -82 -86 -93
Accumulated Other Comprehensive Income / (Loss)		 13 10 11 10 7.50 6.44 3.26

Annual Metrics And Ratios for Universal Health Realty Income Trust

This table displays calculated financial ratios and metrics derived from Universal Health Realty Income Trust's official financial filings.

Metric 2022 2023 2024
Period end date 12/31/2022 12/31/2023 12/31/2024
Growth Metrics		 - - -
Revenue Growth		 7.64% 5.21% 3.85%
EBITDA Growth		 1.48% 2.86% 9.11%
EBIT Growth		 6.24% 1.47% 18.25%
NOPAT Growth		 6.24% 1.47% 18.25%
Net Income Growth		 -80.67% -27.02% 24.90%
EPS Growth		 -80.68% -27.45% 25.23%
Operating Cash Flow Growth		 -1.93% -8.26% 9.25%
Free Cash Flow Firm Growth		 128.14% 86.77% 15.84%
Invested Capital Growth		 1.39% -2.02% -2.25%
Revenue Q/Q Growth		 3.09% -0.04% 0.56%
EBITDA Q/Q Growth		 10.56% -7.23% 1.37%
EBIT Q/Q Growth		 23.95% -14.78% 3.77%
NOPAT Q/Q Growth		 4.56% -2.53% 3.77%
Net Income Q/Q Growth		 -80.29% -11.69% 5.88%
EPS Q/Q Growth		 -80.28% -11.90% 6.11%
Operating Cash Flow Q/Q Growth		 1.65% -4.10% 6.10%
Free Cash Flow Firm Q/Q Growth		 138.94% 22.63% -14.14%
Invested Capital Q/Q Growth		 -0.36% -1.88% -0.23%
Profitability Metrics		 - - -
EBITDA Margin		 63.72% 62.30% 65.45%
EBIT Margin		 33.84% 32.64% 37.16%
Profit (Net Income) Margin		 23.29% 16.15% 19.43%
Tax Burden Percent		 68.81% 49.49% 52.27%
Interest Burden Percent		 100.00% 100.00% 100.00%
Effective Tax Rate		 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 5.40% 5.50% 6.64%
ROIC Less NNEP Spread (ROIC-NNEP)		 2.55% 1.02% 1.81%
Return on Net Nonoperating Assets (RNNOA)		 3.69% 1.67% 3.47%
Return on Equity (ROE)		 9.09% 7.16% 10.11%
Cash Return on Invested Capital (CROIC)		 4.02% 7.53% 8.92%
Operating Return on Assets (OROA)		 5.09% 5.17% 6.25%
Return on Assets (ROA)		 3.50% 2.56% 3.27%
Return on Common Equity (ROCE)		 9.09% 7.16% 10.11%
Return on Equity Simple (ROE_SIMPLE)		 9.21% 7.66% 10.71%
Net Operating Profit after Tax (NOPAT)		 31 31 37
NOPAT Margin		 33.84% 32.64% 37.16%
Net Nonoperating Expense Percent (NNEP)		 2.85% 4.48% 4.83%
SG&A Expenses to Revenue		 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 66.16% 67.36% 62.84%
Earnings before Interest and Taxes (EBIT)		 31 31 37
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 58 59 65
Valuation Ratios		 - - -
Price to Book Value (P/BV)		 2.51 2.77 2.87
Price to Tangible Book Value (P/TBV)		 2.62 2.90 2.99
Price to Revenue (P/Rev)		 6.35 5.83 5.20
Price to Earnings (P/E)		 27.29 36.09 26.79
Dividend Yield		 6.81% 7.16% 7.85%
Earnings Yield		 3.66% 2.77% 3.73%
Enterprise Value to Invested Capital (EV/IC)		 1.59 1.62 1.60
Enterprise Value to Revenue (EV/Rev)		 10.05 9.51 8.85
Enterprise Value to EBITDA (EV/EBITDA)		 15.78 15.27 13.52
Enterprise Value to EBIT (EV/EBIT)		 29.71 29.15 23.82
Enterprise Value to NOPAT (EV/NOPAT)		 29.71 29.15 23.82
Enterprise Value to Operating Cash Flow (EV/OCF)		 19.46 21.12 18.68
Enterprise Value to Free Cash Flow (EV/FCFF)		 39.90 21.27 17.74
Leverage & Solvency		 - - -
Debt to Equity		 1.50 1.79 2.05
Long-Term Debt to Equity		 0.20 0.16 0.11
Financial Leverage		 1.45 1.63 1.91
Leverage Ratio		 2.60 2.80 3.09
Compound Leverage Factor		 2.60 2.80 3.09
Debt to Total Capital		 59.94% 64.14% 67.22%
Short-Term Debt to Total Capital		 52.12% 58.28% 63.69%
Long-Term Debt to Total Capital		 7.82% 5.86% 3.53%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00%
Common Equity to Total Capital		 40.06% 35.86% 32.78%
Debt to EBITDA		 5.94 6.05 5.68
Net Debt to EBITDA		 5.81 5.91 5.57
Long-Term Debt to EBITDA		 0.77 0.55 0.30
Debt to NOPAT		 11.18 11.55 10.01
Net Debt to NOPAT		 10.93 11.29 9.82
Long-Term Debt to NOPAT		 1.46 1.06 0.53
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00%
Liquidity Ratios		 - - -
Cash Flow Metrics		 - - -
Free Cash Flow to Firm (FCFF)		 23 43 49
Operating Cash Flow to CapEx		 343.65% 563.50% 0.00%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00
Efficiency Ratios		 - - -
Asset Turnover		 0.15 0.16 0.17
Fixed Asset Turnover		 0.20 0.21 0.22
Capital & Investment Metrics		 - - -
Invested Capital		 572 560 548
Invested Capital Turnover		 0.16 0.17 0.18
Increase / (Decrease) in Invested Capital		 7.83 -12 -13
Enterprise Value (EV)		 911 907 876
Market Capitalization		 576 556 515
Book Value per Share		 $16.60 $14.54 $12.96
Tangible Book Value per Share		 $15.91 $13.88 $12.43
Total Capital		 572 560 548
Total Debt		 343 359 368
Total Long-Term Debt		 45 33 19
Net Debt		 335 351 361
Capital Expenditures (CapEx)		 14 7.62 0.00
Net Nonoperating Expense (NNE)		 9.56 16 18
Net Nonoperating Obligations (NNO)		 343 359 368
Total Depreciation and Amortization (D&A)		 27 28 28
Earnings Adjustments		 - - -
Adjusted Basic Earnings per Share		 $1.53 $1.12 $1.39
Adjusted Weighted Average Basic Shares Outstanding		 13.77M 13.79M 13.80M
Adjusted Diluted Earnings per Share		 $1.53 $1.11 $1.39
Adjusted Weighted Average Diluted Shares Outstanding		 13.80M 13.81M 13.84M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 13.80M 13.82M 13.85M
Normalized Net Operating Profit after Tax (NOPAT)		 21 22 26
Normalized NOPAT Margin		 23.69% 22.85% 26.01%
Pre Tax Income Margin		 33.84% 32.64% 37.16%
Debt Service Ratios		 - - -
EBIT to Interest Expense		 0.00 0.00 0.00
NOPAT to Interest Expense		 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00
Payout Ratios		 - - -
Dividend Payout Ratio		 185.66% 258.21% 210.01%
Augmented Payout Ratio		 185.66% 258.21% 210.01%

Quarterly Metrics And Ratios for Universal Health Realty Income Trust

This table displays calculated financial ratios and metrics derived from Universal Health Realty Income Trust's official financial filings.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Period end date 9/30/2022 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024
Growth Metrics		 - - - - - - - - - -
Revenue Growth		 4.46% 12.70% 4.74% 7.37% 9.35% -0.17% 8.25% 3.90% 1.12% 2.30%
EBITDA Growth		 -0.79% 38.19% 21.16% 22.88% 7.59% -23.19% 13.06% 15.14% 3.08% 5.69%
EBIT Growth		 0.41% 80.16% 51.08% 51.53% 9.62% -40.51% 21.55% 29.79% 5.79% 16.86%
NOPAT Growth		 0.41% 18.08% 5.56% 1.99% 9.62% -9.24% 21.55% 29.79% 5.79% 16.86%
Net Income Growth		 -9.28% -93.85% -17.50% -33.38% -20.13% -36.19% 18.86% 51.78% 3.23% 29.72%
EPS Growth		 -10.26% -93.83% -17.95% -34.21% -20.00% -36.59% 18.75% 52.00% 3.57% 30.77%
Operating Cash Flow Growth		 -11.32% 6.57% -13.98% -7.42% 6.12% -14.92% 16.59% -1.04% -2.65% 25.81%
Free Cash Flow Firm Growth		 -170.31% 100.87% 105.73% 110.20% 113.49% 2,068.56% 217.95% 156.26% 181.04% 12.41%
Invested Capital Growth		 18.10% 1.39% 0.40% -0.33% -0.50% -2.02% -1.42% -2.50% -3.87% -2.25%
Revenue Q/Q Growth		 -0.09% 8.93% -3.74% 2.50% 1.75% -0.56% 4.37% -1.62% -0.97% 0.60%
EBITDA Q/Q Growth		 20.69% 41.50% -27.24% -1.10% 5.67% 1.01% 7.09% 0.72% -5.39% 3.58%
EBIT Q/Q Growth		 50.24% 81.93% -41.55% -5.15% 8.68% -1.27% 19.44% 1.28% -11.41% 9.06%
NOPAT Q/Q Growth		 1.12% 19.25% -10.82% -5.15% 8.68% -1.27% 19.44% 1.28% -11.41% 9.06%
Net Income Q/Q Growth		 -7.09% 16.15% -20.81% -22.05% 11.39% -7.21% 47.51% -0.45% -24.24% 16.61%
EPS Q/Q Growth		 -7.89% 17.14% -21.95% -21.88% 12.00% -7.14% 46.15% 0.00% -23.68% 17.24%
Operating Cash Flow Q/Q Growth		 -27.65% 28.33% -18.07% 21.71% -17.07% 2.88% 12.27% 3.31% -18.42% 32.95%
Free Cash Flow Firm Q/Q Growth		 11.34% 101.11% 514.94% 68.29% 17.16% 78.85% -9.84% 35.64% 28.49% -28.46%
Invested Capital Q/Q Growth		 0.76% -0.36% -0.22% -0.51% 0.59% -1.88% 0.40% -1.61% -0.82% -0.23%
Profitability Metrics		 - - - - - - - - - -
EBITDA Margin		 63.69% 82.73% 62.53% 60.33% 62.66% 63.65% 65.31% 66.86% 63.87% 65.76%
EBIT Margin		 33.05% 55.20% 33.52% 31.02% 33.13% 32.89% 37.64% 38.75% 34.66% 37.57%
Profit (Net Income) Margin		 21.89% 23.34% 19.20% 14.60% 15.98% 14.92% 21.08% 21.33% 16.32% 18.91%
Tax Burden Percent		 66.22% 64.50% 57.28% 47.07% 48.25% 45.35% 56.01% 55.05% 47.08% 50.34%
Interest Burden Percent		 100.00% 65.55% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 5.48% 5.77% 5.40% 5.09% 5.52% 5.54% 6.46% 6.79% 6.09% 6.71%
ROIC Less NNEP Spread (ROIC-NNEP)		 4.75% 4.85% 4.42% 3.95% 4.33% 4.31% 5.30% 5.58% 4.86% 5.45%
Return on Net Nonoperating Assets (RNNOA)		 8.31% 7.01% 6.54% 6.01% 6.85% 7.03% 9.04% 9.78% 9.03% 10.42%
Return on Equity (ROE)		 13.79% 12.79% 11.94% 11.09% 12.37% 12.57% 15.50% 16.56% 15.12% 17.14%
Cash Return on Invested Capital (CROIC)		 -11.06% 4.02% 5.06% 5.82% 6.07% 7.53% 7.21% 8.78% 10.27% 8.92%
Operating Return on Assets (OROA)		 5.16% 8.30% 5.09% 4.80% 5.19% 5.21% 6.10% 6.40% 5.72% 6.32%
Return on Assets (ROA)		 3.41% 3.51% 2.92% 2.26% 2.51% 2.36% 3.42% 3.52% 2.70% 3.18%
Return on Common Equity (ROCE)		 13.79% 12.79% 11.94% 11.09% 12.37% 12.57% 15.50% 16.56% 15.12% 17.14%
Return on Equity Simple (ROE_SIMPLE)		 45.84% 0.00% 9.07% 8.50% 8.29% 0.00% 8.27% 9.46% 10.00% 0.00%
Net Operating Profit after Tax (NOPAT)		 7.32 8.73 7.79 7.38 8.03 7.92 9.46 9.58 8.49 9.26
NOPAT Margin		 33.05% 36.18% 33.52% 31.02% 33.13% 32.89% 37.64% 38.75% 34.66% 37.57%
Net Nonoperating Expense Percent (NNEP)		 0.73% 0.92% 0.98% 1.14% 1.18% 1.23% 1.17% 1.21% 1.23% 1.26%
SG&A Expenses to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 66.95% 44.80% 66.48% 68.98% 66.87% 67.11% 62.36% 61.25% 65.34% 62.43%
Earnings before Interest and Taxes (EBIT)		 7.32 13 7.79 7.38 8.03 7.92 9.46 9.58 8.49 9.26
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 14 20 15 14 15 15 16 17 16 16
Valuation Ratios		 - - - - - - - - - -
Price to Book Value (P/BV)		 2.28 2.51 2.74 2.82 2.48 2.77 2.53 2.84 3.49 2.87
Price to Tangible Book Value (P/TBV)		 2.38 2.62 2.86 2.94 2.59 2.90 2.65 2.96 3.64 2.99
Price to Revenue (P/Rev)		 6.05 6.35 6.65 6.56 5.46 5.83 5.12 5.51 6.44 5.20
Price to Earnings (P/E)		 4.97 27.29 30.24 33.22 29.86 36.09 30.66 29.99 34.88 26.79
Dividend Yield		 7.34% 6.81% 6.45% 6.45% 7.62% 7.16% 8.02% 7.41% 6.36% 7.85%
Earnings Yield		 20.13% 3.66% 3.31% 3.01% 3.35% 2.77% 3.26% 3.33% 2.87% 3.73%
Enterprise Value to Invested Capital (EV/IC)		 1.51 1.59 1.66 1.68 1.53 1.62 1.52 1.62 1.81 1.60
Enterprise Value to Revenue (EV/Rev)		 9.83 10.05 10.36 10.22 9.15 9.51 8.80 9.15 10.10 8.85
Enterprise Value to EBITDA (EV/EBITDA)		 16.55 15.78 15.76 15.14 13.64 15.27 13.97 14.16 15.56 13.52
Enterprise Value to EBIT (EV/EBIT)		 34.93 29.71 28.53 26.62 23.91 29.15 26.11 25.67 28.05 23.82
Enterprise Value to NOPAT (EV/NOPAT)		 29.46 29.71 30.57 30.54 27.35 29.15 26.11 25.67 28.05 23.82
Enterprise Value to Operating Cash Flow (EV/OCF)		 18.77 19.46 21.03 21.58 19.50 21.12 19.20 20.20 22.50 18.68
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 39.90 32.97 28.79 25.11 21.27 20.95 18.26 17.29 17.74
Leverage & Solvency		 - - - - - - - - - -
Debt to Equity		 1.46 1.50 1.57 1.62 1.72 1.79 1.86 1.90 2.02 2.05
Long-Term Debt to Equity		 0.22 0.20 0.18 0.18 0.19 0.16 0.17 0.10 0.11 0.11
Financial Leverage		 1.75 1.45 1.48 1.52 1.58 1.63 1.71 1.75 1.86 1.91
Leverage Ratio		 2.92 2.60 2.63 2.67 2.74 2.80 2.87 2.92 3.04 3.09
Compound Leverage Factor		 2.92 1.70 2.63 2.67 2.74 2.80 2.87 2.92 3.04 3.09
Debt to Total Capital		 59.30% 59.94% 61.07% 61.85% 63.18% 64.14% 65.08% 65.55% 66.92% 67.22%
Short-Term Debt to Total Capital		 50.54% 52.12% 54.04% 54.85% 56.29% 58.28% 59.30% 61.94% 63.34% 63.69%
Long-Term Debt to Total Capital		 8.75% 7.82% 7.03% 7.00% 6.88% 5.86% 5.78% 3.61% 3.58% 3.53%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 40.70% 40.06% 38.93% 38.16% 36.82% 35.86% 34.92% 34.45% 33.08% 32.78%
Debt to EBITDA		 6.52 5.94 5.78 5.58 5.64 6.05 5.97 5.72 5.75 5.68
Net Debt to EBITDA		 6.36 5.81 5.65 5.43 5.51 5.91 5.85 5.63 5.65 5.57
Long-Term Debt to EBITDA		 0.96 0.77 0.67 0.63 0.61 0.55 0.53 0.31 0.31 0.30
Debt to NOPAT		 11.60 11.18 11.22 11.25 11.30 11.55 11.17 10.37 10.36 10.01
Net Debt to NOPAT		 11.33 10.93 10.95 10.94 11.04 11.29 10.93 10.21 10.18 9.82
Long-Term Debt to NOPAT		 1.71 1.46 1.29 1.27 1.23 1.06 0.99 0.57 0.55 0.53
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - -
Cash Flow Metrics		 - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -81 0.90 5.52 9.28 11 19 18 24 31 22
Operating Cash Flow to CapEx		 0.00% 0.00% 0.00% 0.00% 133.75% 47,522.73% 0.00% 0.00% 0.00% 0.00%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - - - - - - - -
Asset Turnover		 0.16 0.15 0.15 0.15 0.16 0.16 0.16 0.17 0.17 0.17
Fixed Asset Turnover		 0.19 0.20 0.20 0.20 0.21 0.21 0.21 0.22 0.22 0.22
Capital & Investment Metrics		 - - - - - - - - - -
Invested Capital		 574 572 571 568 571 560 563 554 549 548
Invested Capital Turnover		 0.17 0.16 0.16 0.16 0.17 0.17 0.17 0.18 0.18 0.18
Increase / (Decrease) in Invested Capital		 88 7.83 2.27 -1.90 -2.85 -12 -8.08 -14 -22 -13
Enterprise Value (EV)		 864 911 950 953 873 907 856 898 995 876
Market Capitalization		 532 576 609 612 521 556 498 541 634 515
Book Value per Share		 $16.93 $16.60 $16.10 $15.69 $15.22 $14.54 $14.24 $13.79 $13.12 $12.96
Tangible Book Value per Share		 $16.21 $15.91 $15.45 $15.09 $14.52 $13.88 $13.62 $13.20 $12.56 $12.43
Total Capital		 574 572 571 568 571 560 563 554 549 548
Total Debt		 340 343 349 351 361 359 366 363 367 368
Total Long-Term Debt		 50 45 40 40 39 33 33 20 20 19
Net Debt		 332 335 340 342 352 351 358 357 361 361
Capital Expenditures (CapEx)		 0.00 0.00 0.00 0.00 7.60 0.02 0.00 0.00 0.00 0.00
Net Nonoperating Expense (NNE)		 2.47 3.10 3.33 3.91 4.15 4.33 4.16 4.31 4.49 4.60
Net Nonoperating Obligations (NNO)		 340 343 349 351 361 359 366 363 367 368
Total Depreciation and Amortization (D&A)		 6.79 6.64 6.74 6.98 7.15 7.41 6.96 6.95 7.16 6.95
Earnings Adjustments		 - - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.35 $0.41 $0.32 $0.25 $0.28 $0.27 $0.38 $0.38 $0.29 $0.34
Adjusted Weighted Average Basic Shares Outstanding		 13.78M 13.77M 13.78M 13.78M 13.79M 13.79M 13.79M 13.80M 13.81M 13.80M
Adjusted Diluted Earnings per Share		 $0.35 $0.41 $0.32 $0.25 $0.28 $0.26 $0.38 $0.38 $0.29 $0.34
Adjusted Weighted Average Diluted Shares Outstanding		 13.80M 13.80M 13.80M 13.81M 13.82M 13.81M 13.82M 13.83M 13.85M 13.84M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 13.80M 13.80M 13.80M 13.82M 13.82M 13.82M 13.83M 13.85M 13.85M 13.85M
Normalized Net Operating Profit after Tax (NOPAT)		 5.12 6.11 5.45 5.17 5.62 5.55 6.62 6.71 5.94 6.48
Normalized NOPAT Margin		 23.14% 25.33% 23.46% 21.71% 23.19% 23.02% 26.35% 27.12% 24.26% 26.30%
Pre Tax Income Margin		 33.05% 36.18% 33.52% 31.02% 33.13% 32.89% 37.64% 38.75% 34.66% 37.57%
Debt Service Ratios		 - - - - - - - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios		 - - - - - - - - - -
Dividend Payout Ratio		 36.45% 185.66% 195.10% 214.34% 227.19% 258.21% 245.76% 222.18% 221.51% 210.01%
Augmented Payout Ratio		 36.45% 185.66% 195.10% 214.34% 227.19% 258.21% 245.76% 222.18% 221.51% 210.01%

Key Financial Trends

Universal Health Realty Income Trust (NYSE: UHT) has shown steady performance and some key trends over the past four years through its quarterly financial statements.

Positive Trends:

  • Consistent Revenue Stability: Total revenue mainly from non-interest income has remained stable, averaging around $24 million to $25 million quarterly in 2024, indicating steady operational income streams.
  • Growing Net Income: Quarterly net income attributable to common shareholders has increased from approximately $3.5 million in Q2 2023 to $4.7 million in Q4 2024, showing improving profitability.
  • Strong Operating Cash Flow: The company consistently generates substantial net cash from operating activities each quarter, exceeding $9 million regularly and reaching $13.15 million in Q4 2024, demonstrating strong cash generation capability.
  • Dividend Payments Maintained: Dividends per share have been stable or slightly increased, with Q4 2024 paying around $0.73 per share, showing commitment to shareholder returns.
  • Controlled Depreciation Expense: Depreciation expense remains relatively steady at about $6.5 million to $7 million per quarter, which reflects controlled asset aging and investment levels.
  • Manageable Debt Levels: Total liabilities and debt see some fluctuations but the company is actively managing issuance and repayment of debt, with net financing activities mostly reflecting debt repayments balanced by new issuances.
  • Strong Asset Base: Total assets remain robust at around $580 million to $600 million, primarily held in premises and equipment, supporting the company's underlying value.

Neutral Observations:

  • Stable Share Count: Weighted average shares outstanding remain roughly constant around 13.8 million shares, indicating minimal dilution effects.
  • Interest Income / Expense Near Zero: The company reports near zero interest income and expenses, reflecting its business model centered on real estate operations rather than financing income.
  • Minor Variability in Other Operating Expenses: Other operating expenses show some quarter-to-quarter changes, but no significant trends upward or downward, indicating stable operating costs excluding depreciation.

Negative Points:

  • Negative Retained Earnings: Retained earnings have been negative consistently (around -$90 million in recent quarters), which could reflect prior accumulated losses or distributions exceeding earnings, potentially signaling limited earnings retention.
  • High Dividend Payout Relative to Earnings: Dividends paid each quarter are substantial (over $10 million quarterly), which may pressure cash flows, considering net income levels.
  • Declining Equity: Total common equity has decreased from about $233 million in mid-2022 to $182 million by Q3 2024, indicating some erosion in net asset value over time.
  • Negative Other Adjustments to Net Income: The company consistently reports significant negative adjustments reducing consolidated net income, in the range of $4.5 million to $5 million per quarter, which impacts reported earnings.
  • Fluctuating Investing Cash Flows: The company’s cash flows from investing activities show negative values quarterly due to acquisitions or property investments, which could strain liquidity if not matched with operations or financing.

In summary, Universal Health Realty Income Trust maintains solid operational cash flows and stable revenues with a consistent approach to dividends, while facing challenges such as negative retained earnings and declining equity. Investors should monitor the company's ability to sustain dividend payments and improve equity levels going forward.

08/08/25 08:46 PMAI Generated. May Contain Errors.

Frequently Asked Questions About Universal Health Realty Income Trust's Financials

When does Universal Health Realty Income Trust's fiscal year end?

According to the most recent income statement we have on file, Universal Health Realty Income Trust's financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has Universal Health Realty Income Trust's net income changed over the last 2 years?

Universal Health Realty Income Trust's net income appears to be on a downward trend, with a most recent value of $19.23 million in 2024, falling from $21.10 million in 2022. The previous period was $15.40 million in 2023.

How has Universal Health Realty Income Trust's revenue changed over the last 2 years?

Over the last 2 years, Universal Health Realty Income Trust's total revenue changed from $90.63 million in 2022 to $99.01 million in 2024, a change of 9.3%.

How much debt does Universal Health Realty Income Trust have?

Universal Health Realty Income Trust's total liabilities were at $401.32 million at the end of 2024, a 1.5% increase from 2023, and a 6.0% increase since 2022.

How much cash does Universal Health Realty Income Trust have?

In the past 2 years, Universal Health Realty Income Trust's cash and equivalents has ranged from $7.10 million in 2024 to $8.21 million in 2023, and is currently $7.10 million as of their latest financial filing in 2024.

How has Universal Health Realty Income Trust's book value per share changed over the last 2 years?

Over the last 2 years, Universal Health Realty Income Trust's book value per share changed from 16.60 in 2022 to 12.96 in 2024, a change of -21.9%.


Related Companies

This page (NYSE:UHT) was last updated on 8/8/2025 by MarketBeat.com Staff
From Our Partners
HIDDEN IN THE BOOK OF GENESIS…
“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...
Paradigm Press | Sponsored
Trump set to Boost Social Security Checks by 400%?
If you're collecting or planning to collect social security... You should see this presentation about Presi...
InvestorPlace | Sponsored
Amazon’s big Bitcoin embarrassment
Bitcoin just passed Amazon in total market cap — but most investors are missing the bigger opportunity. Whi...
Brownstone Research | Sponsored
BREAKING: The House just passed 3 pro-crypto bills!
THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here.
Crypto 101 Media | Sponsored
Former CIA Officer Reveals How Gold Saved His Life
This isn’t just another gold investing book—it’s a survival playbook written by a former CIA officer trained...
Advantage Gold | Sponsored
Green Light for These Stocks
Guess Who Washington Will Partner With Next? The U.S. government just made a bold $400 million move... beco...
Stansberry Research | Sponsored
GENIUS Act: Cancel Your Money?
A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...
Priority Gold | Sponsored
How high will gold surge?
Weiss Gold Veteran Makes Shocking New Call Weiss expert Sean Brodrick went out on a limb last year and decl...
Weiss Ratings | Sponsored